Intervention Protocol

You have free access to this content

Fibrin-based haemostatic agents for reducing blood loss in adult liver resection

  1. Aimen O Amer1,†,
  2. Colin H Wilson2,‡,*,
  3. Steven A White1,
  4. Derek M Manas2

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 12 DEC 2013

DOI: 10.1002/14651858.CD010872


How to Cite

Amer AO, Wilson CH, White SA, Manas DM. Fibrin-based haemostatic agents for reducing blood loss in adult liver resection (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD010872. DOI: 10.1002/14651858.CD010872.

Author Information

  1. 1

    Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK

  2. 2

    The Freeman Hospital, Institute of Transplantation, Newcastle upon Tyne, Tyne and Wear, UK

  1. These authors contributed equally to this work.

  2. These authors contributed equally to this work.

*Colin H Wilson, Institute of Transplantation, The Freeman Hospital, Freeman Road, High Heaton, Newcastle upon Tyne, Tyne and Wear, NE7 7DN, UK. Colin.Wilson@nuth.nhs.uk. colinwilson2206@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 12 DEC 2013

SEARCH

References

Additional references

Albala 2003
Banninger 1993
Begg 1994
Berrevoet 2007
Boonstra 2009
Brok 2008
  • Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61:763-9.
Brok 2009
  • Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive - trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98.
Clark 1970
Couinaud 1999
CTU 2011
  • Copenhagen Trial Unit. TSA - trial sequential analysis, 2011. ctu.dk/tsa/ (accessed 28 October 2013).
Ding 2013
  • Ding H, Yuan JQ, Zhou JH, Zheng XY, Ye P, Mao C, et al. Systematic review and meta-analysis of application of fibrin sealant after liver resection.. Current Medical Research and Opinion 2013;29(4):387-94.
Egger 1997
Gluud 2013
  • Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al. Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 3. Art. No.: LIVER.
GRADEpro 2008 [Computer program]
  • Brozek J, Oxman A, Schünemann H. GRADEpro. Version 3.2 for Windows. GRADE Working Group, 2008.
Gurusamy 2009a
  • Gurusamy KS, Kumar Y, Ramamoorthy R, Sharma D, Davidson BR. Vascular occlusion for elective liver resections. Cochrane Database of Systematic Reviews 2009, Issue 1. [DOI: 10.1002/14651858.CD007530]
Gurusamy 2009b
  • Gurusamy KS, Li J, Sharma D, Davidson BR. Cardiopulmonary interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD007338]
Gurusamy 2009c
  • Gurusamy KS, Li J, Sharma D, Davidson BR. Pharmacological interventions to decrease blood loss and blood transfusion requirements for liver resection. Cochrane Database of Systematic Reviews 2009, Issue 4. [DOI: 10.1002/14651858.CD008085]
Gurusamy 2009d
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Ibrahim 2006
ICH-GCP 1997
  • International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice1997 CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
Jacobs 2006
  • Jacobs JP, Mavroudis C, Jacobs ML, Maruszewski B, Tchervenkov CI, Lacour-Gayet FG, et al. What is operative mortality? Defining death in a surgical registry database: a report of the STS Congenital Database Taskforce and the Joint EACTS-STS Congenital Database Committee. Annals of Thoracic Surgery 2006;81(5):1937-41.
Jarnagin 2002
  • Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Annals of Surgery 2002;236(4):397-407.
Kjaergard 2001
Koch 2011
  • Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 2011;149(5):680-8.
Langenbuch 1888
  • Langenbuch D. A case of resection of the left lobe of the liver (author's translation) [Ein fall von resektion eines linksseitigen schnurlappens der leber]. Berliner Klinische Wochenschrift 1888;25:37-8.
Lundh 2012
Mintz 2001
  • Mintz PD, Mayers L, Avery N, Flanagan HL, Burks SG, Spotnitz WD. Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive Center. Annals of Clinical and Laboratory Science 2001;31(1):108-18.
Mitsuhata 1994
Moher 1998
  • Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
Mullin 2005
Nakajima 2002
  • Nakajima Y, Shimamura T, Kamiyama T, Matsushita M, Sato N, Todo S. Control of intraoperative bleeding during liver resection: analysis of a questionnaire sent to 231 Japanese hospitals. Surgery Today 2002;32(1):48-52.
Parmar 1998
Rapaport 1992
  • Rapaport SI, Zivelin A, Minow RA, Hunter CS, Donnelly K. Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin. American Journal of Clinical Pathology 1992;97(1):84-91.
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Royle 2003
  • Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
Sanjay 2013
  • Sanjay P, Watt DG, Wigmore SJ. Systematic review and meta-analysis of haemostatic and biliostatic efficacy of fibrin sealants in elective liver surgery. Journal of Gastrointestinal Surgery 2013;17(4):829-36.
Savović 2012
  • Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1-82.
Savović 2012a
  • Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429-38.
Schulz 1995
  • Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273(5):408-12.
Shinozuka 2000
  • Shinozuka N,  Koyama I,  Arai T,  Numajiri Y,  Watanabe T,  Nagashima N,  et al. Autologous blood transfusion in patients with hepatocellular carcinoma undergoing hepatectomy. American Journal of Surgery 2000;179(1):42-5.
Spotnitz 2005
  • Spotnitz WD, Prabhu R. Fibrin sealant tissue adhesive - review and update. Journal of Long-Term Effects of Medical Implants 2005;15(3):245-70.
Thorlund 2009
  • Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses. International Journal of Epidemiology 2009;38(1):276-86.
Thorlund 2010
  • Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology 2010;2:57-66.
Thorlund 2011
  • Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA), 2011. ctu.dk/tsa/files/tsa_manual.pdf (accessed 28 October 2013).
Warvi 1945
Wetterslev 2008
  • Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61:64-75.
Wetterslev 2009
Wood 2008
  • Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.